Citadel Advisors’s Nuvectra Corporation Common Stock NVTR Stock Holding History

Citadel Advisors’s Portfolio NVTR Stock Details NVTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-15,000	Closed	-$20K	–	10186
2019 Q3	$20K	Sell	15,000 -3,000	-17%	-$5.88K	﹤0.01%	8946
2019 Q2	$60K	Buy	+18,000	New	+$114K	﹤0.01%	8674
2018 Q4	–	Sell	-13,000	Closed	-$286K	–	10136
2018 Q3	$286K	Buy	+13,000	New	+$250K	﹤0.01%	7649

Other funds holding NVTR

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

EWM

Edge Wealth Management New York $594M AUM 24.92% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return

Citadel Advisors's NVTR Position: Q4 2019 in Review

Citadel Advisors sold out of Nuvectra Corporation Common Stock (NVTR) in Q4 2019, closing a stake of 17,782 shares — an estimated $24K sold.

Citadel Advisors first reported a position in NVTR in Q2 2018 and held it in 6 quarters. The position peaked at $498K in Q4 2018. 7 funds tracked by Wall St. Rank hold NVTR as of Q4 2019.

Citadel Advisors reported no remaining Nuvectra Corporation Common Stock position as of Q4 2019 after selling out during the quarter.
Citadel Advisors sold 17,782 Nuvectra Corporation Common Stock shares in Q4 2019, an estimated $24K.
Citadel Advisors first reported a position in Nuvectra Corporation Common Stock in Q2 2018 and held it in 6 quarters.
Citadel Advisors's Nuvectra Corporation Common Stock position peaked at $498K in Q4 2018.
7 funds tracked by Wall St. Rank held Nuvectra Corporation Common Stock as of Q4 2019.

Based on Citadel Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.